Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 81
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06136026 | Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer | ||
| NCT05583409 | SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC | ||
| NCT05801133 | Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors | ||
| NCT05372198 | Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line | ||
| NCT03230708 | Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites | ||
| NCT05431621 | Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers | ||
| NCT05004441 | Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer | ||
| NCT07209787 | SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak | ||
| NCT06258863 | Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery | ||
| NCT05621473 | Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC | ||
| NCT07011329 | Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores. | ||
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study | ||
| NCT07250204 | A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation. | ||
| NCT02562599 | Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin | ||
| NCT03210064 | Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients | ||
| NCT05342792 | Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma | ||
| NCT06050109 | The Benefits of Continued Use of Ovarian Function Suppression After 5 Years | ||
| NCT03286348 | Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer | ||
| NCT06279104 | A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary | ||
| NCT06854107 | Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma | ||
| NCT05533892 | Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC | ||
| NCT05044871 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT06280313 | Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension | ||
| NCT06401005 | SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) | ||
| NCT01863303 | Epidemiological Study of Colorectal Cancer in WuHan | ||
| NCT04214782 | Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm | ||
| NCT03482089 | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion | ||
| NCT04125849 | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer | ||
| NCT03716245 | Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer | ||
| NCT04074538 | the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium | ||
| NCT01616849 | Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma | ||
| NCT06402435 | SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer | ||
| NCT03595644 | Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer | ||
| NCT05159167 | Impact of Baduanjin Qigong Exercise on Fatigue in Patients With NSCLC Undergoing Adjuvant Chemotherapy | ||
| NCT06020430 | Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | ||
| NCT06810492 | The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment | ||
| NCT02605265 | Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 | ||
| NCT03662633 | Diagnosis Value of SEMA4C in Breast Cancer | ||
| NCT05520801 | Primary Hepatobiliary Cancer Cohort of Central China | ||
| NCT05448703 | A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis | ||
| NCT06470256 | Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma | ||
| NCT06713421 | Effect of Premedication With Pronase on Mucosal Cleanliness During EGD | ||
| NCT07264998 | Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea | ||
| NCT01271439 | Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma | ||
| NCT03663153 | SEMA4C as a Relapse Biomarker in Breast Cancer | ||
| NCT05992870 | Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction | ||
| NCT02094638 | Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study | ||
| NCT05713994 | Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma | ||
| NCT04079283 | Radiomics of Immunotherapeutics Response Evaluation and Prediction | ||
| NCT04735861 | Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma |
